The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) announced Wednesday it has launched a clean stock protocol: a proprietary process to certify the company's cannabis clones are free of pests and pathogens.
The Toronto-headquartered cannabis firm said the use of the clean stock protocol is in addition to the industry-standard certificates of authenticity that attest to THC and CBD content.
In other encouraging news, the firm also announced it has made the first delivery shipment of clones.
"Growers in Saskatchewan will have the opportunity to benefit from genetics that are certified under the Clean Stock Protocol during the first growing season in Canada," noted the firm in a statement.
As only licenced cannabis retailers are permitted to sell clones in Saskatchewan, the firm is working with Railway Distributing as its wholesale and distribution partner in the province. Railway will oversee the retail availability of Flowr’s clones throughout the province.
“We are excited to partner with Railway to bring our trusted cannabis cultivars to the Saskatchewan market as an initial phase of our planned nursery business,” said Jason Broome, Flowr’s Chief Research and Innovation Officer. “Growing cannabis is challenging and by providing clones that are certified clean, we are aiming to assist growers by reducing uncertainty and enhancing the likelihood of a successful harvest.”
The company said the clean stock protocol was developed in partnership with Hawthorne Canada Limited, a subsidiary of The Scotts Miracle-Gro Company (NYSE:SMG) the well-known supplier of lawn, garden and hydroponics products.
Flowr, through its subsidiaries, holds a cannabis production and sales licence granted by Health Canada.
Headquartered in Toronto with a production facility in Kelowna, British Columbia, Flowr builds and operates large-scale, cultivation facilities utilizing its own patented growing systems. When fully completed, Flowr’s Kelowna campus is expected to produce over 50,000 kg of premium flower annually.
Flowr is expanding globally in Portugal and Australia, and is developing a 50,000 sq/ft R&D facility in partnership with Hawthorne.
Shares of Flowr were up 8.3% at C$6.16 on Wednesday.
Contact Katie Lewis at [email protected]